In the TrkA-expressing CRC cell line KM12, the selective TrkA inhibitor NMS-P626 effectively inhibits TrkA phosphorylation and downstream signaling, demonstrating significant antitumor activity in mice with xenograft tumors [189]. Here, NTRK1 is linked to colorectal carcinoma.